Patent classifications
C07D215/04
HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME
The present application provides a hetero-cyclic compound which may significantly improve the service life, efficiency, electrochemical stability, and thermal stability of an organic light emitting device, and an organic light emitting device in which the hetero-cyclic compound is contained in an organic compound layer.
Quinolines and process for the preparation thereof
The present invention discloses novel N-Heterocyclic compounds of formula A, [Formula A] And a ligand-enabled palladium-catalyzed process for preparation of novel N-Heterocyclic compounds of Formula A via CH alkynylation of N-heterocycles with alkynyl halides. ##STR00001##
Quinolines and process for the preparation thereof
The present invention discloses novel N-Heterocyclic compounds of formula A, [Formula A] And a ligand-enabled palladium-catalyzed process for preparation of novel N-Heterocyclic compounds of Formula A via CH alkynylation of N-heterocycles with alkynyl halides. ##STR00001##
IMMUNOREGULATORY AGENTS
- Hilary Plake Beck ,
- Juan Carlos Jaen ,
- Maksim Osipov ,
- Jay Patrick Powers ,
- Maureen Kay Reilly ,
- Hunter Paul Shunatona ,
- James Ross Walker ,
- Mikhail Zibinsky ,
- James Aaron Balog ,
- David K. Williams ,
- Jay A. Markwalder ,
- Steven P. Seitz ,
- Emily Charlotte Cherney ,
- Liping Zhang ,
- Weifang Shan ,
- Weiwei Guo ,
- Audris Huang
Compounds that modulate the oxidoreductase enzyme indoleamine 2,3-dioxygenase, and compositions containing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by indoleamine 2,3-dioxygenase is also provided.
HALOGENATED QUINOLINE DERIVATIVES AS ANTIMICROBIAL AGENTS
The present invention provides halogenated quinoline derivatives, such as compounds of Formula (I) or (I), and pharmaceutically acceptable salts thereof, and methods of preparing the halogenated quinoline derivatives. The halogenated quinoline derivatives are expected to be antimicrobial agents and may act through an iron(II)-dependent mode of action. The present invention also provides pharmaceutical compositions, kits, uses, and methods that involve the halogenated quinoline derivatives and may be useful in preventing or treating a microbial infection (e.g., a bacterial infection) in a subject, inhibiting the growth and/or reproduction of a microorganism (e.g., a bacterium), killing a microorganism (e.g., a bacterium), inhibiting the formation and/or growth of a biofilm, reducing or removing a biofilm, and/or disinfecting a surface.
##STR00001##
HALOGENATED QUINOLINE DERIVATIVES AS ANTIMICROBIAL AGENTS
The present invention provides halogenated quinoline derivatives, such as compounds of Formula (I) or (I), and pharmaceutically acceptable salts thereof, and methods of preparing the halogenated quinoline derivatives. The halogenated quinoline derivatives are expected to be antimicrobial agents and may act through an iron(II)-dependent mode of action. The present invention also provides pharmaceutical compositions, kits, uses, and methods that involve the halogenated quinoline derivatives and may be useful in preventing or treating a microbial infection (e.g., a bacterial infection) in a subject, inhibiting the growth and/or reproduction of a microorganism (e.g., a bacterium), killing a microorganism (e.g., a bacterium), inhibiting the formation and/or growth of a biofilm, reducing or removing a biofilm, and/or disinfecting a surface.
##STR00001##
COMPOSITIONS AND METHODS FOR TREATING TUBERCULOSIS
The present invention provides compounds for the treatment of a bacterial infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the treatment of a bacterial infection in a subject.
NOVEL QUINOLINE DERIVATIVES AND PREPARATION THEREOF
The patent discloses novel quinoline derivatives of formula (I), (Formula should be inserted here) and process for preparing the same. The compounds of formula (I) can be further used for the synthesis of Inhibitors like Kinase Tyrosine Inhibitors.
##STR00001##
FLUORESCENCE-BASED CHEMICAL DETECTION OF AMINE-BASED SUBSTANCES
Various techniques are provided to determine the presence of trace chemicals corresponding to various materials of interest. In one example, a method includes providing a chemical reporter of a chemical detector. The chemical reporter includes protonated 2-[5-methoxy-2-(4-phenyl-quinoline-2yl)-phenyl]-ethanol. A vapor-phase amine compound is subsequently received at the chemical reporter. The chemical detector then detects a response of the chemical reporter to the amine compound to determine whether materials of interest are present. Additional methods and related devices are also provided.
FLUORESCENCE-BASED CHEMICAL DETECTION OF AMINE-BASED SUBSTANCES
Various techniques are provided to determine the presence of trace chemicals corresponding to various materials of interest. In one example, a method includes providing a chemical reporter of a chemical detector. The chemical reporter includes protonated 2-[5-methoxy-2-(4-phenyl-quinoline-2yl)-phenyl]-ethanol. A vapor-phase amine compound is subsequently received at the chemical reporter. The chemical detector then detects a response of the chemical reporter to the amine compound to determine whether materials of interest are present. Additional methods and related devices are also provided.